Fluorinated diaryl sulfides as serotonin transporter ligands: Synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents

Journal of Medicinal Chemistry

Volumn 48, Issue 7, 2005, Pages 2559-2570

  Huang, Yiyun ^a   Bae, Sung A ^a   Zhu, Zhihong ^a   Guo, Ningning ^a   Roth, Bryan L ^b   Laruelle, Marc ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(2 AMINO 4 FLUOROMETHYLPHENYL)THIO] N,N DIMETHYLBENZENEMETHANAMINE; 2 [(2 AMINO 4 FLUOROPHENYL)THIO] N,N DIMETHYLBENZENEMETHANAMINE; 2 [[2 AMINO 4 (2 FLUOROETHYL)PHENYL]THIO] N,N DIMETHYLBENZENEMETHANAMINE; 2 [[2 AMINO 4 (3 FLUOROPROPYL)PHENYL]THIO] N,N DIEMTHYLBENZENEMETHANAMINE; DOPAMINE TRANSPORTER; FLUORINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; NORADRENALIN TRANSPORTER; RADIOLIGAND; SEROTONIN TRANSPORTER; SULFIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BENZENE DERIVATIVES; BINDING, COMPETITIVE; BRAIN; CELL LINE; FLUORINE RADIOISOTOPES; HUMANS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFIDES; TISSUE DISTRIBUTION;

EID: 17144418906     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0400808     Document Type: Article

References (59)

1. Lucki, I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 1998, 44, 151-162.
2. Blakely, R. D.; De Felice, L. J.; Hartzell, H. C. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 1994, 196, 263-281.
3. Mann, J. J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999, 27, 99S-105S.
4. Mann, J. J.; Huang, Y. Y.; Underwood, M. D.; Kassir, S. A.; Oppenheim, S.; Kelly, T. M.; Dwork, A. J.; Arango, V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 2000, 57, 729-738.
5. Deakin, J. F. The role of serotonin in panic, anxiety and depression. Int. Clin. Psychopharmacol. 1998, 13 Suppl 4, S1-5.
6. Chen, C. P.; Alder, J. T.; Bowen, D. M.; Esiri, M. M.; McDonald, B.; Hope, T.; Jobst, K. A.; Francis, P. T. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J. Neurochem. 1996, 66, 1592-1598.
7. Abi-Dargham, A.; Laruelle, M.; Aghajanian, G. K.; Charney, D.; Krystal, J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J. Neuropsych. Clin. Neurosci. 199, 1-17.
8. Hyttel, J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol. 1994, 1, 19-26.
9. 11C]AFM. J. Cereb. Blood Flow Metab. 2002, 22, 1377-1398.
10. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J. Med. Chem. 1991, 34, 3144-3146.
11. Goodman, M. M.; Chen, P.; Plisson, C.; Martarello, L.; Galt, J.; Votaw, J. R.; Kilts, C. D.; Malveaux, G.; Camp, V. M.; Shi, B.; Ely, T. D.; Howell, L.; McConathy, J.; Nemeroff, C. B. Synthesis and characterization of iodine-123 labeled 2β-carbomethoxy-3β-(4′-((Z)-2-iodoethenyl)phenyl) nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. J. Med. Chem. 2003, 46, 925-935.
12. Plisson, C.; McConathy, J.; Martarello, L.; Malveaux, E. J.; Camp, V. M.; Williams, L.; Votaw, J. R.; Goodman, M. M. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2β-carbomethoxy- 3β-[4′-((Z)-2-halo-ethenyl)phenyl]tropanes: Candidate radioligands for in vivo imaging of the serotonin transporter. J. Med. Chem. 2004, 47, 1122-1135.
13. 11C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nucl. Med. Biol. 2002, 29, 651-656.
14. Jagust, W. J.; Eberling, J. L.; Biegon, A.; Taylor, S. E.; Van-Brocklin, H. F.; Jordan, S.; Hanrahan, S. M.; Roberts, J. A.; Brennan, K. M.; Mathis, C. A. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J. Nucl. Med. 1996, 37, 1207-1214.
15. Karramkam, M.; Dolle, F.; Valette, H.; Besret, L.; Bramoulle, Y.; Hinnen, F.; Vaufrey, F.; Franklin, C.; Bourg, S.; Coulon, C.; Ottaviani, M.; Delaforge, M.; Loc'h, C.; Bottlaender, M.; Crouzel, C. Synthesis of a fluorine-18-labelled derivative of 6-nitro-quipazine as a radioligand for the in vivo serotonin transporter imaging with PET. Bioorg. Med. Chem. 2002, 10, 2611-2623.
16. Lundkvist, C.; Loc'h, C.; Halldin, C.; Bottlaender, M.; Ottaviani, M.; Coulon, C.; Fuseau, C.; Mathis, C.; Farde, L.; Maziere, B. Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter. Nucl. Med. Biol. 1999, 26, 501-507.
17. 11C](+)McN5652. Synapse 1995, 20, 37-43.
18. 11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Life Sci. 1993, 53, 883-892.
19. Suehiro, M.; Scheffel, U.; Dannals, R. F.; Ravert, H. T.; Ricaurte, G. A.; Wagner, H., Jr. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. J. Nucl. Med. 1993, 34, 120-127.
20. 11C]McN 5652. J. Nucl. Med. 2000, 41, 1465-1477.
21. 11C]McN5652: a serotonin transporter radioligand. J. Cereb. Blood Flow Metab. 1999, 19, 967-981.
22. 11C](+)-McN-5652: assessment of methods. J. Cereb. Blood Flow Metab. 2000, 20, 253-262.
23. Ferris, R. M.; Brieaddy, L.; Mehta, N.; Hollingsworth, E.; Rigdon, G.; Wang, C.; Soroko, F.; Wastila, W.; Cooper, B. Pharmacological properties of 403U76, a new chemical class of 5-hydroxy-tryptamine- and noradrenaline-reuptake inhibitor. J. Pharm. Pharmacol. 1995, 47, 775-781.
24. 123I]IDAM. Eur. J. Nucl. Med. 1999, 26, 854-861.
25. 123I]IDAM, 5-iodo-2-((2-((di-methylamino)methyl) phenyl)thio)benzyl alcohol. J. Med. Chem. 1999, 42, 333-335.
26. 123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters. Eur. J. Nucl. Med. 1999, 26, 844-853.
27. Oya, S.; Choi, S.; Hou, C.; Mu, M.; Kung, M.; Acton, P. D.; Siciliano, M.; Kung, H. F. 2-((2-((dimethylamino)methyl)phenyl)-thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. Nucl. Med. Biol. 2000, 27, 249-254.
28. 125I]ADAM to serotonin transporters in rat brain. Synapse 2000, 38, 403-412.
29. 123I]ADAM and SPECT. J. Nucl. Med. 2001, 42, 1556-1562.
30. 11C-labelled 2-(aryl-thio)benzylamines: Potential radiotracers for the serotonin reuptake receptor. J. Labelled Compd. Radiopharm. 1999, 42, 1277-1288.
31. 11C-labeled 2-(phenylthio)araalkylamines. J. Med. Chem. 2000, 43, 3103-3110.
32. 11C]-DASB. Eur. J. Nucl. Med. 2000, 27, 1719-1722.
33. 11C]-DASB binding to the human serotonin transporter: modeling strategies. J. Cereb. Blood Flow Metab. 2001, 21, 1342-1353.
34. 11C]DASB PET imaging study. Am. J. Psychiatry 2001, 158, 1843-1849.
35. Chalon, S.; Tarkiainen, J.; Garreau, L.; Hall, H.; Emond, P.; Vercouillie, J.; Farde, L.; Dasse, P.; Varnas, K.; Besnard, J. C.; Halldin, C.; Guilloteau, D. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4- methylphenylthio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. J. Pharmacol. Exp. Ther. 2003, 304, 81-87.
36. Tarkiainen, J.; Vercouillie, J.; Emond, P.; Sandell, J.; Hiltunen, J.; Frangin, Y.; Guilloteau, D.; Halldin, C. Carbon-11 labeling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter. J. Labelled Compd. Radiopharm. 2001, 44, 1013-1023.
37. 11C]DAPA). Nucl. Med. Biol. 2002, 29, 741-751.
38. 11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics. Nucl. Med. Biol. 2004, 31, 983-994.
39. 11C]AFA). Nucl. Med. Biol. 2004, 31, 727-738
40. 11C]AFM). Nucl. Med. Biol. 2004, 31, 543-556.
41. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23, 1096-1112.
42. 11C-McN 5652 in healthy humans. J. Nucl. Med. 2004, 45, 682-694.
43. 18F] fluoroethyl analogue of McN5652.Nucl. Med. Biol. 1996, 23, 407-412.
44. Marjamaki, P.; Zessin, J.; Eskola, O.; Gronroos, T.; Haaparanta, M.; Bergman, J.; Lehikoinen, P.; Forsback, S.; Brust, P.; Steinbach, J.; Solin, O. S-[18F]fluoromethyl-(+)-MeN5652, a PET tracer for the serotonin transporter: Evaluation in rats. Synapse 2003, 47, 45-53.
45. 18F]fluoromethyl)-(+)-McN5652. Neuropsychopharmacology 2003, 28, 2010-2019.
46. 18F]fluoromethyl)-(+)-McN5652. Synapse 2003, 47, 143-151.
47. 18F]ACF (2-[(2-amino-4-chloro-5- fluorophenyl)thio]-N,N-dimethyl-benzenmethanamine). J. Med. Chem. 2002, 45, 4716-4723.
48. 18F]fluorophenylthio)benzylamine as a serotonin transporter imaging agent. Appl. Radiat. Isot. 2003, 58, 183-191.
49. 18F-ADAM): An improved PET radioligand for serotonin transporters. J. Nucl. Med. 2003, 44, 1890-1897.
50. Huang, Y.; Bae, S. A.; Zhu, Z.; Guo, N.; Hwang, D. R.; Laruelle, M. Fluorinated analogues of ADAM as new PET radioligands for the serotonin transporter: Synthesis and pharmacological evaluation. J. Labelled Compd. Radiopharm. 2001, 44, S18-S20.
51. Lal, G. S.; Pez, G. P.; Pesaresi, R. J.; Prozonic, F. M.; Cheng, H. Bis(2-methoxyethyl)aminosulfur trifluoride: a new broad-spectrum deoxofluorinating agent with enhanced thermal stability. J. Org. Chem. 1999, 64, 7048-7054.
52. Brieaddy, L. E. Substituted diphenylsulfides as serotonin uptake inhhibitors. WO 93/12080, 1993.
53. Mehta, N. B.; Hollingsworth, C. E.; Brieaddy, L. E.; Cooper, B. R. Halogen substituted diphenylsulfides. EP0402097, 1997.
54. Polivka, Z.; Silhankova, A.; Sindelar, K.; Mickova, R.; Valenta, V.; Krejci, I. Derivatives of N,N-dimethyl-2-(arylthio)benzyl-amine, their salts, methods of preparation and their use in pharmaceutical medicaments. WO 97/17325, 1997.
55. Emond, P.; Vercouillie, J.; Innis, R.; Chalon, S.; Mavel, S.; Frangin, Y.; Halldin, C.; Besnard, J. C.; Guilloteau, D. Substituted diphenyl sulfides as selective serotonin transporter ligands: synthesis and in vitro evaluation. J. Med. Chem. 2002, 45, 1253-1258.
56. 18F-ADAM): as a serotonin transporter imaging agent. J. Nucl. Med. 2003, 44, 185P.
57. Choi, S. R.; Oya, S.; Kung, H. F. Structure activity relationship of analogues of ADAM as ligands for serotonin transporters. J. Labelled Compd. Radiopharm. 2001, 42, S190-S192.
58. Oya, S.; Kung, M. P.; Hou, C.; Acton, P. D.; Mu, M.; Kung, H. F. Structure activity relationship of IDAM and its derivatives as serotonin trasnsporter imaging agents. J. Labelled Compd. Radiopharm. 2001, 42, S57-S58.
59. 18F]fluoromethyl)-(+)-McN5652. Eur. Neuropsychopharmacol. 2003, 13, 387-397.